ASCO 2011 Breast Cancer Symp - Thursday

$San Francisco, CA - Breast Cancer Symposium 2011 - The Continuum of Breast Care: Science to Survivorship - J. Xie (instead of E. Q. Wu) presents the Abstract #151: "Number needed to treat and treatment cost per fracture avoided with denosumab compared to zoledronic acid in patients with breast cancer with bone metastases" during Oral Abstract Session B at the Breast Cancer Symposium here today, Friday September 9, 2011 at the San Francisco Marriott. Over 1100 attendees received updates on the latest research in breast cancer detection, care, prevention and treatment from physicians, clinicians and researchers from around the world. Date: Friday September 9, 2011 Photo by © ASCO/Todd Buchanan 2011 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.$

59 / 60

San Francisco, CA - Breast Cancer Symposium 2011 - The Continuum of Breast Care: Science to Survivorship - J. Xie (instead of E. Q. Wu) presents the Abstract #151: "Number needed to treat and treatment cost per fracture avoided with denosumab compared to zoledronic acid in patients with breast cancer with bone metastases" during Oral Abstract Session B at the Breast Cancer Symposium here today, Friday September 9, 2011 at the San Francisco Marriott. Over 1100 attendees received updates on the latest research in breast cancer detection, care, prevention and treatment from physicians, clinicians and researchers from around the world. Date: Friday September 9, 2011 Photo by © ASCO/Todd Buchanan 2011 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.